[HTML][HTML] Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel
M AlHarbi, NA Mobark, WAR AlJabarat, H ElBardis… - Oncotarget, 2023 - ncbi.nlm.nih.gov
Family history is an important factor in determining hereditary cancer risk for many cancer
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
[PDF][PDF] Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel
M AlHarbi, NA Mobark, WAR AlJabarat, H ElBardis… - 2023 - researchgate.net
Family history is an important factor in determining hereditary cancer risk for many cancer
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel
M AlHarbi, NA Mobark, WAR AlJabarat… - …, 2023 - pure.johnshopkins.edu
Family history is an important factor in determining hereditary cancer risk for many cancer
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
[HTML][HTML] Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel
M AlHarbi, NA Mobark, WAR AlJabarat, H ElBardis… - Oncotarget, 2023 - oncotarget.com
Abstract Musa AlHarbi 1, Nahla Ali Mobark 1, Wael Abdel Rahman AlJabarat 1, Hadeel
ElBardis 2, Ebtehal AlSolme 2, Abdullah Bany Hamdan 3, Ali H. AlFakeeh 1, Fatimah …
ElBardis 2, Ebtehal AlSolme 2, Abdullah Bany Hamdan 3, Ali H. AlFakeeh 1, Fatimah …
Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel
M AlHarbi, NA Mobark, WAR AlJabarat… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Family history is an important factor in determining hereditary cancer risk for many cancer
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
M AlHarbi, NA Mobark, WAR AlJabarat, H ElBardis… - Oncotarget, 2023 - europepmc.org
Family history is an important factor in determining hereditary cancer risk for many cancer
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
[引用][C] Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel
M AlHarbi, NA Mobark, WAR AlJabarat, H ElBardis… - 2023 - europepmc.org
Family history is an important factor in determining hereditary cancer risk for many cancer
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
[PDF][PDF] Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel
M AlHarbi, NA Mobark, WAR AlJabarat, H ElBardis… - 2023 - researchgate.net
Family history is an important factor in determining hereditary cancer risk for many cancer
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
types. The emergence of next-generation sequencing (NGS) has expedited the discovery of …
Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel
M AlHarbi, NA Mobark, WAR AlJabarat, H ElBardis… - Oncotarget, 2023 - oncotarget.com
Abstract Musa AlHarbi 1, Nahla Ali Mobark 1, Wael Abdel Rahman AlJabarat 1, Hadeel
ElBardis 2, Ebtehal AlSolme 2, Abdullah Bany Hamdan 3, Ali H. AlFakeeh 1, Fatimah …
ElBardis 2, Ebtehal AlSolme 2, Abdullah Bany Hamdan 3, Ali H. AlFakeeh 1, Fatimah …